GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by Jacobs Levy Equity Management Inc.

Jacobs Levy Equity Management Inc. raised its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 17.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,731,313 shares of the company's stock after buying an additional 259,316 shares during the period. Jacobs Levy Equity Management Inc. owned about 0.38% of GE HealthCare Technologies worth $162,484,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. LGT Financial Advisors LLC lifted its position in GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock worth $25,000 after acquiring an additional 251 shares in the last quarter. Fred Alger Management LLC purchased a new stake in shares of GE HealthCare Technologies during the second quarter valued at approximately $26,000. Capital Performance Advisors LLP acquired a new position in shares of GE HealthCare Technologies during the third quarter worth $26,000. Ashton Thomas Securities LLC purchased a new position in shares of GE HealthCare Technologies in the third quarter valued at $26,000. Finally, Elkhorn Partners Limited Partnership acquired a new stake in GE HealthCare Technologies during the 2nd quarter valued at $31,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have weighed in on GEHC shares. Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a research report on Thursday, October 31st. JPMorgan Chase & Co. initiated coverage on GE HealthCare Technologies in a report on Monday, September 9th. They issued a "neutral" rating and a $90.00 price target for the company. Evercore ISI lifted their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an "outperform" rating in a report on Tuesday, October 1st. UBS Group cut GE HealthCare Technologies from a "neutral" rating to a "sell" rating and reduced their target price for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. Finally, BTIG Research upgraded shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 price target for the company in a research note on Wednesday, September 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $95.46.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the business's stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the transaction, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.27% of the stock is currently owned by insiders.

GE HealthCare Technologies Stock Performance

GEHC traded down $0.51 on Tuesday, hitting $82.57. 2,026,619 shares of the company's stock were exchanged, compared to its average volume of 3,063,322. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The stock has a fifty day moving average of $87.62 and a two-hundred day moving average of $83.67. GE HealthCare Technologies Inc. has a twelve month low of $67.00 and a twelve month high of $94.55. The firm has a market cap of $37.72 billion, a PE ratio of 22.68, a P/E/G ratio of 2.97 and a beta of 1.07.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.06 by $0.08. The business had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business's revenue was up .9% on a year-over-year basis. During the same quarter last year, the business posted $0.99 EPS. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.17%. The ex-dividend date of this dividend is Tuesday, January 14th. This is a boost from GE HealthCare Technologies's previous quarterly dividend of $0.03. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.30%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.